The IPO of Rays of Belief, the firm behind Mom's Belief, saw 1.18x subscription on its first day, led by 6.51x demand from retail investors. The company seeks to raise ₹125 crore to fund the expansion of its neurodevelopmental therapy centers. Investors are balancing growth plans against risks like high staffing costs and valuation concerns.
Rays of Belief, which operates therapy centers under the 'Mom's Belief' brand, opened its initial public offering (IPO) on September 1, 2026. By the close of the first day, the issue was subscribed 1.18 times, according to exchange data. The demand was primarily driven by retail investors, who applied for 6.51 times the shares reserved for them. Non-institutional investors subscribed to 0.39 times their quota, while institutional buyers remained on the sidelines during the initial session.
The company is looking to raise ₹125 crore through this IPO. It is a completely fresh issue of 52.30 lakh shares, meaning all proceeds will go toward the company’s business needs rather than providing an exit to existing shareholders. Before the public opening, the firm secured ₹50 crore from anchor investors, signaling some institutional interest ahead of the retail bidding process.
Expansion Plans and Capital Use
Rays of Belief focuses on providing therapy for children with neurodevelopmental disorders like autism, ADHD, and cerebral palsy. The company has ambitious growth plans, aiming to open 319 new therapy centers between fiscal 2027 and 2029. The funds raised will be used for setting up these facilities, purchasing therapy equipment, and covering technology costs. While this shows a clear path for revenue growth, the execution will be a key factor for investors to track.
Operational Risks and Financial Context
Investors looking at the business model should note several specific risks. The company’s operations depend heavily on hiring and retaining skilled clinical staff, which results in significant employee benefit expenses. This is a common challenge for service-led healthcare firms, as rising wage costs can pressure profit margins. Furthermore, while the company is scaling up, some of its domestic centers are currently operating at EBITDA-neutral levels, meaning they are barely covering their own operating costs before accounting for broader corporate expenses.
The company also relies on its subsidiaries in the United States, which adds a layer of geographical dependency to its financials. Additionally, some market analysts have flagged the IPO's valuation as aggressive, suggesting the price-to-earnings ratio is on the higher side. Whether the company can justify this valuation through rapid scaling and improved profitability in its domestic centers will be a critical question for shareholders in the coming years.
The subscription window closes on September 3, 2026. Following the end of the bidding process, the shares are tentatively scheduled to list on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) on September 8, 2026. Investors may continue to monitor the subscription trend in the institutional and non-institutional categories over the next two days for a better gauge of overall market sentiment.